| Literature DB >> 24310294 |
Masahiro Osumi1, Hideichi Wada, Yuichi Morita, Masayuki Shimizu, Yuta Sukehiro, Mau Amako, Noritoshi Minematsu, Hitoshi Matsumura, Masaru Nishimi, Tadashi Tashiro.
Abstract
OBJECTIVE: Antegrade central perfusion for acute Stanford type A aortic dissection prevents malperfusion and retrograde cerebral embolism during cardiopulmonary bypass. Prompt establishment of antegrade perfusion via the ascending aorta may improve surgical results of type A dissections, especially in situations of hemodynamic instability. Thus, we evaluated the safety and efficacy of cannulation of the dissected ascending aorta in acute type A dissection.Entities:
Mesh:
Year: 2013 PMID: 24310294 PMCID: PMC4004845 DOI: 10.1007/s11748-013-0355-9
Source DB: PubMed Journal: Gen Thorac Cardiovasc Surg ISSN: 1863-6705
Fig. 1A single pledgeted 4–0 polypropylene mattress suture was placed at the left lateral aspect of the ascending aorta
Fig. 2To ensure correct positioning of the tip of the arterial cannula in the true lumen by epiaortic ultrasound guidance
Fig. 3A 16-French, heparin-coated, flexible, thin-walled cannula (Fem-Flex II Femoral Arterial Cannulae; Edwards Life Sciences LLC, Midvale, UT, USA) was inserted into the aorta using Seldinger technique
Preoperative patients’ characteristics
| Variable | Central group ( | Peripheral group ( |
|
|---|---|---|---|
| Age (mean ± SD) | 71.7 ± 10.4 | 67.1 ± 11.1 | 0.34 |
| Female gender | 19 (29.4 %) | 13 (69.5 %) | 0.001 |
| Hypertension | 24 (70.5 %) | 14 (60.8 %) | 0.15 |
| Diabetes mellitus | 4 (11.7 %) | 1 (6.7 %) | 0.41 |
| COPD | 1 (2.9 %) | 1 (4.3 %) | 0.62 |
| Renal dysfunction (Cre >1.5) | 2 (5.8 %) | 2 (8.6 %) | 0.83 |
| Previous stroke | 6 (17.6 %) | 5 (21.7 %) | 0.65 |
Dissection-related complications
| Variable | Central group, | Peripheral group, |
|
|---|---|---|---|
| Pericardiac effusion | 15 (51.7) | 13 (56.5) | 0.53 |
| Aortic valve regurgitation | 3 (10.3) | 4 (17.3) | 0.61 |
| Cardiac tamponade | 3 (10.3) | 2 (8.6) | 0.82 |
| Shock | 3 (10.3) | 2 (8.6) | 0.74 |
| Myocardial ischemia | 1 (3.4) | 1 (4.3) | 0.82 |
| Cerebral ischemia | 5 (20.6) | 6 (26.0) | 0.48 |
| Limb ischemia | 0 (0) | 1 (4.3) | 0.44 |
Operative data
| Central group ( | Peripheral group ( |
| |
|---|---|---|---|
| Hemiarch replacement | 25 (86.2 %) | 16 (69.5 %) | 0.36 |
| Total arch replacement | 4 (13.7 %) | 7 (30.4 %) | 0.21 |
| Concomitant procedure | 0 (0 %) | 2 (2.1 %) 1; AVR 1; CABG | 0.22 |
| Operative time (min) | 381.4 | 512.5 | <0.001 |
| CPB time (min) | 209.4 | 232.9 | <0.001 |
Postoperative data
| Central group ( | Peripheral group ( |
| |
|---|---|---|---|
| Reoperation for bleeding | 1 (3.4 %) | 1 (4.7 %) | 0.29 |
| Deep sternal infection | 1 (3.4 %) | 1 (4.7 %) | 0.64 |
| Permanent stroke | 2 (6.8 %) | 3 (13.0 %) | 0.24 |
| Respiratory failure | 3 (10.2 %) | 3 (13.0 %) | 0.41 |
| Intubation time (h) | 90.8 ± 71.2 | 80.8 ± 61.2 | 0.03 |
| Mortality (30 days) | 2 (6.8 %) | 4 (17.3 %) | <0.001 |